X
UTHR icon

Xponance’s United Therapeutics UTHR Stock Holding History

Xponance’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07M Sell
7,508
-274
-4% -$154K 0.03% 430
2026
Q1 		$4.61M Buy
7,782
+1,121
+17% +$558K 0.03% 375
2025
Q4 		$3.25M Sell
6,661
-1,022
-13% -$476K 0.02% 433
2025
Q3 		$3.22M Buy
7,683
+241
+3% +$81K 0.03% 427
2025
Q2 		$2.14M Buy
7,442
+25
+0.3% +$7.47K 0.02% 521
2025
Q1 		$2.29M Buy
7,417
+67
+0.9% +$23K 0.02% 493
2024
Q4 		$2.59M Buy
7,350
+605
+9% +$222K 0.02% 462
2024
Q3 		$2.42M Sell
6,745
-134
-2% -$45.3K 0.02% 469
2024
Q2 		$2.19M Sell
6,879
-838
-11% -$222K 0.02% 474
2024
Q1 		$1.77M Buy
7,717
+2,116
+38% +$477K 0.02% 550
2023
Q4 		$1.23M Buy
5,601
+7
+0.1% +$1.61K 0.01% 602
2023
Q3 		$1.26M Sell
5,594
-105
-2% -$24.2K 0.02% 583
2023
Q2 		$1.26M Sell
5,699
-407
-7% -$90.2K 0.02% 588
2023
Q1 		$1.37M Buy
6,106
+73
+1% +$18K 0.02% 556
2022
Q4 		$1.68M Buy
6,033
+622
+11% +$157K 0.03% 491
2022
Q3 		$1.13M Sell
5,411
-27
-0.5% -$6.04K 0.02% 536
2022
Q2 		$1.28M Buy
5,438
+399
+8% +$81.1K 0.03% 506
2022
Q1 		$904K Sell
5,039
-18
-0.4% -$3.43K 0.02% 629
2021
Q4 		$1.09M Sell
5,057
-58
-1% -$11.4K 0.02% 573
2021
Q3 		$944K Sell
5,115
-174
-3% -$34.3K 0.02% 589
2021
Q2 		$949K Buy
5,289
+559
+12% +$106K 0.02% 620
2021
Q1 		$791K Buy
4,730
+4
+0.1% +$667 0.02% 566
2020
Q4 		$717K Buy
4,726
+1
+0% +$131 0.02% 592
2020
Q3 		$477K Buy
4,725
+696
+17% +$76.4K 0.01% 663
2020
Q2 		$488K Buy
+4,029
New +$453K 0.01% 619

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Xponance's UTHR Position: Q2 2026 in Review

Xponance reduced its United Therapeutics (UTHR) stake by 3.5% in Q2 2026, selling an estimated $154K and leaving 7,508 shares worth $4.07M. The position accounts for 0.03% of the portfolio, ranked #430.

Xponance first reported a position in UTHR in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.61M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Xponance held 7,508 shares of United Therapeutics worth $4.07M as of Q2 2026.
  • Xponance sold 274 United Therapeutics shares in Q2 2026, an estimated $154K.
  • United Therapeutics made up 0.03% of Xponance's portfolio in Q2 2026, its #430 holding.
  • Xponance first reported a position in United Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Xponance's United Therapeutics position peaked at $4.61M in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.